100 related articles for article (PubMed ID: 3230345)
1. [Inhibition of pulmonary metastasis in mice by OK-432--MCT emulsion administrated enterally].
Masuyama K; Tazawa K; Kasagi T; Yamashita I; Ishizawa S; Fujimaki M; Ochiai H; Niwayama S; Matsui H
Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1300-6. PubMed ID: 3230345
[No Abstract] [Full Text] [Related]
2. [Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].
Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T
Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2179-87. PubMed ID: 6530585
[No Abstract] [Full Text] [Related]
3. [Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].
Nio Y; Inamoto T; Kan N; Hori T; Nakayama N; Yamasaki N; Hikasa Y; Tsuchitani T; Ban S; Nagai T
Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):803-10. PubMed ID: 6491430
[No Abstract] [Full Text] [Related]
4. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
Nio Y; Inamoto T; Hori T; Kan N; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):597-608. PubMed ID: 4056544
[No Abstract] [Full Text] [Related]
5. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
[No Abstract] [Full Text] [Related]
6. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
[TBL] [Abstract][Full Text] [Related]
8. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
Mukai M; Ando K; Koike S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
[TBL] [Abstract][Full Text] [Related]
9. The effect of large dose intratumoral administration of OK-432 in advanced cancer patients.
Sakamoto J; Kondo T; Kamei H; Ichihashi H; Yamamura Y
Nagoya J Med Sci; 1979 Dec; 42(1-2):27-36. PubMed ID: 530302
[No Abstract] [Full Text] [Related]
10. [Combined effect of the topical administration of OK-432 with radiation on the C3H mouse fibrosarcoma (NFSa)--TCD50 and the mechanism of action].
Mukai M; Ando K; Koike S; Nagao K; Isono K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3432-5. PubMed ID: 3789754
[TBL] [Abstract][Full Text] [Related]
11. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T; Ohgaki K
Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):609-17. PubMed ID: 2932509
[No Abstract] [Full Text] [Related]
13. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
[TBL] [Abstract][Full Text] [Related]
14. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
Nio Y; Ohgaki K; Kan N; Tsuchitani T; Imai S; Okino T; Hori T; Tobe T; Nakamura M; Kodama H
Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2436-45. PubMed ID: 3449590
[No Abstract] [Full Text] [Related]
15. [NK activities in cancer patients--their modification by an immunopotentiator].
Sasanami T; Fujishima A; Moriya Y; Imai K; Yachi A
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2186-92. PubMed ID: 7184392
[TBL] [Abstract][Full Text] [Related]
16. [Local immunotherapy for cancer].
Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
[TBL] [Abstract][Full Text] [Related]
17. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
[TBL] [Abstract][Full Text] [Related]
18. OK-432 stimulates primary production and activity of murine natural killer cells.
Pollack SB
Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
[TBL] [Abstract][Full Text] [Related]
19. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
[No Abstract] [Full Text] [Related]
20. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]